Bergman,Jack

Institution: McLean Hospital/Harvard Medical School, USA

Top Collaborators: Paronis CA, Nikas SP, Vemuri VK, Makriyannis A, Thakur GA, Bajaj S, Mello NK, Fivel PA, Kohut SJ, Kangas BD, Desai RI, Delatte MS, Pettersson B, Subramanian KV, Rydbeck A, Shukla VG, Martin J, Desai R

Research Interests: Ability, Dopamine, Drugs, Rats, Monkeys, Amphetamine, Cocaine, D-amphetamine, Methamphetamine, Administration, Behavior, Food, Injection, Rhesus Monkeys, Time, Tetrahydrocannabinol, Discrimination, Primates, Lithium, Quinazolines

Publications
Grants

Information and abstracts for author publications
Published Date	Impact	Publication
10/17/2012	7.8	Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology Effects of chronic buspirone treatment on cocaine self-administration.	Abstract
11/04/2010	3.8	The Journal of pharmacology and experimental therapeutics Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal.	Abstract
09/16/2010	3.8	The Journal of pharmacology and experimental therapeutics Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds.	Abstract
02/26/2010	3.8	The Journal of pharmacology and experimental therapeutics Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux.	Abstract
01/03/2013	3.8	The Journal of pharmacology and experimental therapeutics Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists.	Abstract
09/27/2012	3.8	The Journal of pharmacology and experimental therapeutics Diuretic effects of cannabinoids.	Abstract
02/05/2009	3.7	Organic & biomolecular chemistry Synthesis of 1,4-benzodiazepin-3-ones and 1,5-benzodiazocin-4-ones by addition of Grignard reagents to derivatives of o-aminobenzonitrile.	Abstract
06/22/2013	3.1	Animal cognition Repeated acquisition and discrimination reversal in the squirrel monkey (Saimiri sciureus).	Abstract

Grants Recieved by this author
Budget Start	Budget End	Grant Type	Project Cost	Project Title
9/30/2010	8/31/2014	NIH R01: Research Project	$2,243,945	Candidate Medications for Cannabis Addiction: FAAH Inhibitors
7/01/2013	6/30/2014	NIH R01: Research Project	$523,748	Preclinical Evaluation of Medications to Treat Polydrug Addiction
7/01/2011	4/30/2014	NIH R01: Research Project	$1,258,273	Alpha Adrenergic Pharmacotherapy for Polydrug (Stimulant/Opiate) Abuse
9/01/2008	8/31/2010	NIH R01: Research Project	$466,102	CB-1 Antagonists for Cannabis Addiction

Bergman,Jack

Related JoVE Videos